Skip to content

Immunity against SARS-Coronavirus 2 in breast milk

Immunity against SARS-Coronavirus 2 in breast milk - COVID MILK

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49658
Enrollment
55
Registered
2020-04-17
Start date
2020-04-24
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corona virus COVID 19

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Lactating mothers with a proven COVID-19 infection

Exclusion criteria

Exclusion criteria: No infection

Design outcomes

Primary

MeasureTime frame
Neutralizing antibodies, IgG, IgA and IgM against SARS-CoV2 will be determined in the collected blood samples. Secretory IgA will be assessed in breast milk samples before and after Holder pasteurization.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)